Top Funding Rounds: Biotech and AI Lead with Big Wins
Biotech and AI sectors see major funding, with Candid Therapeutics' $370M and Glean's $260M rounds leading the way this week.
- Latest
- Trending
Biotech and AI sectors see major funding, with Candid Therapeutics' $370M and Glean's $260M rounds leading the way this week.
Explore how U.S. states are leading AI regulation efforts, focusing on industry-specific and high-risk AI systems.
Investors can navigate Wells Fargo's stock amidst recent regulatory challenges with strategic insights for potential growth.
A security flaw in Apple's Vision Pro headset could infer data from gaze typing. It's patched in visionOS 1.3.
The U.S. Commerce Department's AI proposal could increase compliance costs and shift the global AI landscape.
Suffolk County urged to hire IT staff, security chief, and get cyber insurance post-cyberattack analysis.
US House passes bill limiting tax credits for EVs using Chinese battery tech, impacting US-China carmaker deals.
Consumers' Research alerts public on Tether risks, citing false claims and lack of transparency, urging caution.
The Pentagon employs AI to upgrade old software, overcoming tech and policy hurdles for IT modernization.
Google's 2019 ad tech changes face scrutiny in U.S. antitrust trial, impacting publishers' ad revenue strategies.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.